36 years with F.Hoffmann La Roche (FHLR) where he held several senior executive positions. During his tenure, he lead the Strategic Marketing of Oncology/Virology/Antiinfectives Units. Thereafter he expanded his area of responsibilty to Pharma Operational Head and Chairman for 110 countries in the Central Estern Europe, Central Asia, Indian subcontinant, Middle East and Africa. In addition to above duties, he designed and build the worldwide Emerging Markets Strategy for FHLR.
Graduated from Boston University and completed Bachelor of Science in Economics focusing on healthcare economics. Received MBA from Babson College with a final thesis in Central Eastern European pharmaceutical industry. Held various financial positions in Health and Finance sector. Also Board Member in various Turkish based companies.
Graduated from Boğaziçi University Business Administration and Economics Departments as a double major degree. He started his career in Pfizer and assumed Finance Specialist, Treasury and Accounts Payable Manager, Business Finance and Pricing Manager of Turkey/ Caucasus /Central Asia Region roles respectively. In this period, he held responsibilities on Wyeth acquisition, other M&A projects, FCPA/SOX audits and pricing. Following that, he gained experience on marketing in Pfizer and worked as Product Manager of 5 different, both pre-launch and promoted products; finally he was appointed as Retail Manager. He joined TRPharm as Finance and Business Development Director in July 2013 and assumed Country Manager Turkey role as of October 2017.
After graduating from Kuleli Military High School in 2001, he completed Internal Medicine in 2008 and Medical Oncology training in 2012 at GATA Haydarpaşa Training Hospital. He began working at AstraZeneca as Group Medical Manager, Associate Professor of Medicine as of January 2015. Dr. Tolga Tunçel appointed as Medical Director / Oncology – Hemotology at TRPharm on July 2016. He will be responsible for expending the existing medical team and developing the product portfolio of TRPharm with his expertise on Oncology.
Belgin Özdilsiz who received her MBA degree from Yeditepe University after graduating from the Faculty of Medicine of Marmara University, was appointed as Medical Director of Rare Diseases to TRPharm. She has worked as a physician in Çamlıca Ömür Hospital between 2000 and 2001, and continued her career from 2001 to 2014 chronologically as, a Medical advisor in Sanovel, Product Manager and Medical Manager in Ali Raif Pharmaceuticals, Medical Manager in Meda Pharmaceuticals and Medical Manager, Senior Medical Manager and Group Medical Manager in GlaxoSmithKline. Before joining TRPharm, Özdilsiz served as Medical and Regulatory Affairs Director and Head of Medical Affairs in Sanofi Genzyme between 2014 and 2017.
Graduated from University of Damascus Faculty of Pharmacy. Started his career as medical representative in United Arab Emirates with Glaxo, later on he joined Roche in the Middle East for more than 20 years and had a variety of different responsibilities and positions in Sales, Marketing and Countries/Regions Management in UAE, Oman, Yemen, Kuwait, Lebanon, Jordan, Iraq, Palestine and Syria. Prior to joining TRPharm he spent the past 4 years as Roche General Manager -Saudi Arabia.